MIT professor was an early Moderna investor, now his stake is worth $1.4b
The biotech firm reported encouraging early trial results for an experimental COVID-19 vaccine, sending the value of Bob Langer's 3.2 per cent stake soaring.
from Sydney Morning Herald - Business https://ift.tt/3g844L5 Read More
No comments:
Post a Comment
Thank You for sharing your views. I hope you like the arts posted.
No comments:
Post a Comment
Thank You for sharing your views. I hope you like the arts posted.